Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in Italy

Clin Infect Dis. 2015 Jan 1;60(1):159-61. doi: 10.1093/cid/ciu736. Epub 2014 Sep 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / methods*
  • Developed Countries
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Infant, Newborn
  • Italy
  • Patient Acceptance of Health Care*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*

Substances

  • Anti-Retroviral Agents